XANRA 30 MG is a pharmaceutical medication that contains Mirtazapine, an antidepressant belonging to the class of noradrenergic and specific serotonergic antidepressants (NaSSAs). It is primarily used for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). Mirtazapine works by enhancing the activity of serotonin and norepinephrine in the brain, which helps improve mood, reduce anxiety, and alleviate symptoms of depression.
XANRA 30 MG is typically prescribed when other antidepressants have not been effective, or when a more sedating effect is desired, as it also has a mild sedative property. This makes it useful for patients who experience sleep disturbances alongside depression or anxiety. The 30 mg dosage is commonly used for moderate to severe cases of depression, and it is typically taken as a once-daily oral tablet, preferably at night to minimize daytime sedation.